The Mycelium Report
Dispatches from The Mycelium Report — curated from medical journals, research papers, podcasts, and news outlets around the world.
Never Miss What Matters
One weekly email. The best psilocybin research, podcasts, and news from trusted sources around the world — no searching required.
Psilocybin Integration: Mapping Post-Psychedelic Challenges
The Post-Psychedelic Challenges Project at Emory University is recruiting 800 adults who have experienced difficulties during or after psychedelic use. The observational study tracks symptoms, functioning, and recovery…
Psilocybin and Aging: What Early Research Suggests
Researchers at Baylor College of Medicine are investigating whether psilocybin can influence biological markers associated with brain aging, based on preclinical work. The source is a press article…
Functional Mushrooms for Well-Being: What the Science Says
A 2023 study from the Queensland Brain Institute found that compounds in lion’s mane may promote neuron growth and new connections between brain cells, with possible implications for…
Microdosing Psilocybin for Mental Health: What the Research Shows
Several early studies suggest that sub-hallucinogenic doses of psilocybin, taken on intermittent schedules, may support mood and reduce depressive symptoms. One systematic study found benefits in people without…
Psilocybin for Veterans: Bill Proposes $30M in Federal Funding
The Innovative Therapies Centers of Excellence Act of 2025, a bipartisan Senate bill, would allocate $30 million per year to fund at least five VA medical facilities offering…
Functional Mushrooms and the Hype Cycle: What the Science Actually Says
In a December 2025 podcast conversation, UK-based fungi educator Oli Genn-Bash argued that the functional mushroom market is accelerating past its evidence base. Drawing on lion’s mane as…
Psilocybin and Aging: What a New Review Found
A 2024 review paper by Mark Haden and colleagues, published in a peer-reviewed outlet and summarized by Drug Science, argues that psilocybin and other psychedelics may affect multiple…
Psilocybin Approval: FDA Hears Debate on Access and Safety
On September 14, 2026, the FDA held a public hearing to gather input on how psychedelic medicines should be used after approval. Speakers disagreed sharply on provider qualifications,…
Psilocybin and Anxiety: A Hippocampal Reset Theory
A theoretical paper published in Psychopharmacology in 2026 proposes that anxiety disorders may involve a kind of stuck pattern in the hippocampus, a brain structure central to memory…
Psilocybin for Traumatic Brain Injury: What a Narrative Review Found
A narrative review indexed on NIH platforms examined the possible mechanisms by which psilocybin could support recovery from traumatic brain injury, focusing on neuroplasticity pathways. The review is…
You've Come This Far. Stay Informed.
Join our free weekly newsletter and get the best psilocybin research, medical journals, podcasts, and news — hand-curated from trusted sources around the world and delivered straight to your inbox.